Author details

Full Name

Andrew Tonkin

Affiliation

ORCID

Career Start Year

1973

Papers

433

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37036703	Associations of Change in Body Size With All-Cause and Cause-Specific Mortality Among Healthy Older Adults.	JAMA Netw Open	2023
35972369	Association between popliteal artery wall thickness and structural progression in patients with symptomatic knee osteoarthritis.	Rheumatology	2023
37951294	Low-dose aspirin and incident atrial fibrillation in healthy older individuals: a post-hoc analysis of the ASPREE Trial.		2023
37948123	Long-term occupational exposures on disability-free survival and mortality in older adults.		2023
38038339	Low-density-lipoprotein cholesterol and mortality outcomes among healthy older adults: A post-hoc analysis of ASPREE trial.		2023
37938756	Lipoprotein(a), platelet function and cardiovascular disease.		2023
37929782	Genome-Wide Association Study of Cardiovascular Resilience Identifies Protective Variation in the <i>CETP</i> Gene.	J Am Heart Assoc	2023
37745426	Expanded statistical analysis plan for legacy and long-term effects of aspirin in the ASPREE-XT observational follow-up study of participants in the ASPREE randomized trial.		2023
37821846	Association of a healthy lifestyle with mortality in older people.		2023
37984339	Cardiovascular Disease Risk Scores and Incident Dementia and Cognitive Decline in Older Men and Women.		2023
37879942	Association Between Triglycerides and Risk of Dementia in Community-Dwelling Older Adults: A Prospective Cohort Study.		2023
37552955	Compliance-Adjusted Estimates of Aspirin Effects Among Older Persons in the ASPREE Randomized Trial.	Am J Epidemiol	2023
37610595	Sex-dependent associations of plasma high-density lipoprotein cholesterol and mortality risk in healthy older men and women: two prospective cohort studies.		2023
36841547	The cost-effectiveness of coronary calcium score-guided statin therapy initiation for Australians with family histories of premature coronary artery disease.		2023
36652261	Association of Plasma High-Density Lipoprotein Cholesterol Level With Risk of Fractures in Healthy Older Adults.		2023
36882434	Associations of body size with all-cause and cause-specific mortality in healthy older adults.		2023
37012015	Statins for extension of disability-free survival and primary prevention of cardiovascular events among older people: protocol for a randomised controlled trial in primary care (STAREE trial).		2023
36693423	Estrone, sex hormone binding globulin and lipid profiles in older women: an observational study.	Climacteric	2023
36993471	Association of a Healthy Lifestyle with Mortality in Older People.		2023
37168270	The association between frailty and incident cardiovascular disease events in community-dwelling healthy older adults.		2023
36921646	The Association Between PCSK9 Inhibitor Use and Sepsis: A Systematic Review and Meta-Analysis of 20 Double-Blind, Randomized, Placebo-Controlled Trials.		2023
36856152	Cognitive trajectories and incident dementia after a cardiovascular event in older adults.	Alzheimers Dement	2023
37291001	The Effects of Statins on Cardiovascular and Inflammatory Biomarkers in Primary Prevention: A Systematic Review and Meta-Analysis.		2023
37097768	Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial.	Age Ageing	2023
35224525	A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial data.	Lancet Healthy Longev	2022
36175048	Aspirin for Primary Prevention of Cardiovascular Events in Relation to Lipoprotein(a) Genotypes.	J Am Coll Cardiol	2022
35766272	B-Type Natriuretic Peptide and Long-Term Cardiovascular Mortality in Patients With Coronary Heart Disease.	Journal of the American Heart Association	2022
35760597	Impact of Blood Lipids on 10-Year Cardiovascular Risk in Individuals Without Dyslipidemia and With Low Risk Factor Burden.	Mayo Clin Proc	2022
35383832	Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open Label Extension of the COMPASS trial.	Eur Heart J Cardiovasc Pharmacother	2022
36091679	Effect of atorvastatin on skeletal muscles of patients with knee osteoarthritis: analysis of a randomised controlled trial.	Frontiers in Medicine	2022
36203169	Examining evidence of time-dependent treatment effects: an illustration using regression methods.	Trials	2022
35727884	Does Aspirin Prevent Incident Heart Failure in Healthy Older Adults? Examining the Evidence From the ASPREE Trial.	Circulation: Heart Failure	2022
35985663	Prescribed opioid use is associated with adverse cardiovascular outcomes in community-dwelling older persons.	ESC heart failure	2022
35410519	The Association of Dispositional Optimism and Pessimism With Cardiovascular Disease Events in Older Adults: A Prospective Cohort Study.	Journal of Aging and Health	2022
35722878	Variation in Mean Arterial Pressure Increases Falls Risk in Elderly Physically Frail and Prefrail Individuals Treated With Antihypertensive Medication.	Hypertension	2022
36959831	Trajectories of physical health-related quality of life and the risk of incident cardiovascular disease events and all-cause mortality in older people.		2022
37117752	Trajectories of depressive symptoms in older adults and associated health outcomes.	Nat Aging	2022
34852379	The PAR4 Platelet Thrombin Receptor Variant rs773902 does not Impact the Incidence of Thrombotic or Bleeding Events in a Healthy Older Population.	Thrombosis and Haemostasis	2022
35252940	Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial.	Lancet Healthy Longev	2022
34718513	Alcohol consumption and risks of cardiovascular disease and all-cause mortality in healthy older adults.	European Journal of Preventive Cardiology	2022
35179040	Circulating Cystatin C Is an Independent Risk Marker for Cardiovascular Outcomes, Development of Renal Impairment, and Long-Term Mortality in Patients With Stable Coronary Heart Disease: The LIPID Study.	Journal of the American Heart Association	2022
34949098	Prognostic Value of a Polygenic Risk Score for Coronary Heart Disease in Individuals Aged 70 Years and Older.	Circulation. Genomic and precision medicine	2022
34762275	Cardiovascular risk prediction in healthy older people.	Geroscience	2022
34698889	Comparison of statins for primary prevention of cardiovascular disease and persistent physical disability in older adults.	European Journal of Clinical Pharmacology	2022
35286146	Safety of Ceasing Aspirin Used Without a Clinical Indication After Age 70 Years: A Subgroup Analysis of the ASPREE Randomized Trial.	Ann Intern Med	2022
35264114	Common genetic variants do not predict recurrent events in coronary heart disease patients.	BMC Cardiovasc Disord	2022
34657596	Statistical reanalysis of vascular event outcomes in primary and secondary vascular prevention trials.	BMC Medical Research Methodology	2021
34176293	Long-Term Blood Pressure Variability and Risk of Cognitive Decline and Dementia Among Older Adults.	J Am Heart Assoc	2021
34167639	Effect of Statin Therapy on CognitiveÂ Decline and Incident DementiaÂ in Older Adults.	J Am Coll Cardiol	2021
33957178	Risk stratification of cardiovascular complications using CHADS-VASc and CHADS scores in chronic atherosclerotic cardiovascular disease.	International Journal of Cardiology	2021